STOCK TITAN

Neumora Therapeutics: Paul L Berns reports 5.4% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Neumora Therapeutics, Inc. (NMRA) ownership disclosure lists Paul L Berns, the reporting person, as beneficially owning 10,201,627 shares, or 5.4%, as of September 30, 2026. The amount comprises 7,708,851 common shares and options to purchase 2,492,776 shares that were vested or would vest within 60 days. The stated percentage is based on 187,895,912 common shares outstanding as of August 10, 2026; the disclosure says the options were included in that count.

Beneficially owned shares 10,201,627 shares Paul L Berns as of September 30, 2026
Class ownership 5.4% Reported percentage of the class
Common shares 7,708,851 shares Record shares beneficially owned as of September 30, 2026
Options to purchase common shares 2,492,776 shares Options vested or to vest within 60 days as of September 30, 2026
Common shares outstanding 187,895,912 shares As of August 10, 2026; the disclosure says the Berns Options were included
beneficial owner regulatory
"Berns is the beneficial owner of 7,708,851 shares"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
Sole Voting Power regulatory
"Sole Voting Power 10,201,627.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
Sole Dispositive Power regulatory
"Sole Dispositive Power 10,201,627.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Neumora Therapeutics (NMRA) shares did Paul L Berns beneficially own?

Paul L Berns reported beneficial ownership of 10,201,627 shares, or 5.4%, as of September 30, 2026. The amount includes common shares and options to purchase common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





640979100

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



Paul L Berns
Signature:/s/ Paul L Berns
Name/Title:Paul L Berns
Date:11/16/2026

Keep reading